P/E Ratio (TTM)
-17.95
BioNTech SE currently has a P/E ratio of -17.95. The P/E ratio is a primary valuation multiple used to determine if a stock is overvalued or undervalued relative to its earnings.
Quarterly P/E
| Quarter | P/E Ratio |
|---|---|
| 2018-03-31 | -54.04 |
| 2018-06-30 | -54.04 |
| 2018-09-30 | -31.39 |
| 2018-12-31 | -544.08 |
| 2019-03-31 | -18.10 |
| 2019-06-30 | -14.86 |
| 2019-09-30 | -24.72 |
| 2019-12-31 | -29.88 |
| 2020-03-31 | -53.53 |
| 2020-06-30 | -39.89 |
| 2020-09-30 | -16.71 |
| 2020-12-31 | 11.87 |
| 2021-03-31 | 5.04 |
| 2021-06-30 | 4.19 |
| 2021-09-30 | 4.56 |
| 2021-12-31 | 4.14 |
| 2022-03-31 | 2.68 |
| 2022-06-30 | 5.53 |
| 2022-09-30 | 4.97 |
| 2022-12-31 | 3.81 |
| 2023-03-31 | 13.72 |
| 2023-06-30 | -31.17 |
| 2023-09-30 | 37.27 |
| 2023-12-31 | 12.33 |
| 2024-03-31 | -16.26 |
| 2024-06-30 | -5.44 |
| 2024-09-30 | 32.44 |
| 2024-12-31 | 25.16 |
| 2025-03-31 | -11.91 |
| 2025-06-30 | -14.27 |
| 2025-09-30 | -173.12 |
| 2025-12-31 | -16.50 |
Annual P/E
| Year | P/E Ratio |
|---|
* P/E ratios are calculated using trailing twelve-month (TTM) earnings. Extreme values may indicate earnings anomalies or cyclical volatility.